ID
32084
Beskrivning
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form is only for documentation of unplanned stool samples in case of gastroenteritis epidoseds during the trial. Planned stool samples at pre-defined timepoints need to be recorded in the "planned stool sample" form for visits 3 and 5.
Länk
https://clinicaltrials.gov/ct2/show/NCT00139334
Nyckelord
Versioner (1)
- 2018-10-17 2018-10-17 - Sarah Riepenhausen
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
17 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Gastroenteritis stools collection
- StudyEvent: ODM
Similar models
Gastroenteritis stools collection
- StudyEvent: ODM
C1550661 (UMLS CUI-2)
C1299222 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])